You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Concurrent chemoradiotherapy in non‐small cell lung cancer
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2010
|
| DOI | 10.1002/14651858.cd002140.pub3 |
| Pubmed ID | |
| Authors |
Noelle O'Rourke, Marta Roqué i Figuls, Nuria Farré Bernadó, Fergus Macbeth |
| Abstract |
This is an updated version of the original review published in Issue 4, 2004. The use of concurrent chemotherapy and radiotherapy in non-small cell lung cancer (NSCLC) might be seen as a way of increasing the effectiveness of radical radiotherapy at the same time as reducing the risks of metastatic disease. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 274 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | <1% |
| Germany | 1 | <1% |
| Australia | 1 | <1% |
| Austria | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 267 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 40 | 15% |
| Student > Master | 32 | 12% |
| Student > Ph. D. Student | 31 | 11% |
| Other | 30 | 11% |
| Student > Bachelor | 22 | 8% |
| Other | 62 | 23% |
| Unknown | 57 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 135 | 49% |
| Nursing and Health Professions | 12 | 4% |
| Biochemistry, Genetics and Molecular Biology | 11 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 3% |
| Social Sciences | 6 | 2% |
| Other | 27 | 10% |
| Unknown | 75 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2014.
All research outputs
#19,985,400
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,899
of 11,842 outputs
Outputs of similar age
#86,718
of 96,738 outputs
Outputs of similar age from Cochrane database of systematic reviews
#69
of 76 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,738 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.